Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Mediwound ( (MDWD) ) has provided an update.
MediWound Ltd. announced the approval of its 2024 Share Incentive Plan at a special shareholder meeting. With 88% of the votes in favor, the plan involves rolling over 280,375 ordinary shares from the expiring 2014 Equity Incentive Plan, which is expected to enhance employee engagement and retention, potentially influencing the company’s market position positively.
More about Mediwound
MediWound Ltd. operates in the biotechnology industry, specializing in the development and commercialization of therapeutic products for tissue repair and regeneration. The company is headquartered in Yavne, Israel, and focuses primarily on innovative treatments for burns, chronic wounds, and other skin injuries.
YTD Price Performance: 69.12%
Average Trading Volume: 45,802
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $185.5M
Find detailed analytics on MDWD stock on TipRanks’ Stock Analysis page.
